March 01, 2010      

IMRIS Inc. (TSX:IM), a provider of neurosurgical, neurovascular, and cardiovascular interventional suites that incorporate real-time imaging systems, continued a string of positive news with the acquisition of NeuroArm Surgical Ltd. (NASL), a privately held developer of magnetic resonance-compatible neurosurgical robot technology. IMRIS will issue 1.6 million common shares, worth somewhere north of $10.7 million, to acquire all of NeuroArm's technology, patents, and associated intellectual prope...

Thank You for Reading Robotics Business Review!

Reading this content requires a free membership.
To continue reading, please sign up for an RBR Insider account.